Table II.
Analysis of the concentrations of calprotectin in stools depending on clinical symptoms
| Clinical symptom | Average concentration of calprotectin [ng/ml] | Number of patients with elevated concentration of calprotectin | Statistical significance, p |
|---|---|---|---|
| Pancreatic failure n = 41/41 |
1276.0 | 4/41 | NS |
| Recurrent diarrhoea n = 4/41 |
2206.7 | 2/4 | < 0.05 |
| Deficiency of body mass n = 15/41 |
1444.1 | 2/15 | NS |
| Low concentration of protein and/or albumins n = 14/41 |
1109.14 | 2/14 | < 0.05 |
| Symptoms from the respiratory tract n = 23/41 |
1417.5 | 2/23 | NS |
| Liver damage n = 4/41 |
1263.0 | 1/4 | NS |
| History of meconium ileus n = 5/41 |
1372.3 | 1/5 | NS |
| Electrolytes disturbances n = 3/41 |
1562.5 | 1/3 | NS |